that would be big pharma. joining me is kaiser health news sarah warne. and drugmakers and health care companies have decided they aren't cutting ties with russia. thank you for being here. i want to put on the screen a paragraph from your piece. you quote abbott labs vice president who says as a health care company, we have an important purpose, which at this time, we continue to separate and serve people for essential products. this name is scott stopple, and then abbott is identified as selling drugs for oncology, women's health, pancreatic insufficienty and liver health. >> the russians are dependent on them to help produce drugs inside the country and implication of drugs. about 20 years or so ago, 90% of drugs were imported from outside the country. this is a huge priority for vladimir putin to really build up domestic manufacturing of pharmaceuticals. he formed partnerships with eli lilly, with abbott, with pfizer, they have come in and helped build facilities there and they're crucial for the pharmaceutical industry inside of russia. >> is this a

the people must always come before big pharma. we are finally taking action to cut the price of insulin. the affordable insulin now act would cap out-of-pocket costs for insulin for monthly supply at $35 and require plans to cover different types of insulin. the -- the speaker pro tempore: the gentleman's time has expired. mr. carter: we must do this now. i yield back. mr. desaulnier: i reserve. the speaker pro tempore: the gentleman's time has expired. the gentlewoman from north carolina is recognized. ms. foxx: thank you, madam speaker. madam speaker, i cannot let go past one of our colleagues saying before that we don't believe in helping average people. yes we do. republicans are here every day. we are average people. we are here to help average people. but what we believe in most of all is freedom for americans, and we happen to believe that democrats don't believe in that. this bill is an exemplar of the fact that they want the government to control our lives. in every way they possibly k in the past democrats and republican

big pharma has the right at whatever price that once you can expect medicare to pay them in the drugompanies that maintain the system and protect their cash cow. in addition with those escalating pharmaceutical cost between other countries the united states phases appear other countries is down here and in addition for those that are escalating also going after supply teens going after the playbook that raise prices for american consumers and here's an example of the 20th century mobile was the beating heart of american manufacturing congress now realizes in addition to the importance of the automobile comment chips are hugely important because the time we get up in the morning until the time we go to bed peter chips are critical between energy economy and manufacturing and on the trade front to have a bipartisan proposal and senator schumer will call on my colleague. when we hear how america will compete in markets all of us believe senator cantwell. >> . >> thank you leader schumer for his introduction of us innovation and competition act. we can see today how important supply chai

making big pharma negotiate on medicare.cal companies gouge people with diabetes. making billionaires pay their fair share. i mean, these are -- again, these are 90/10 issues. joe biden, it seems, tried to speak to the middle of this country and also to the very things you all work on every day. >> i agree. i agree with adrienne in what was said. it was a moment of unity. you could see republicans and democrats coming together on ukraine, standing up for democracy, of course, and also on issues like affordability, whether it is prescription drugs or making sure people could afford gas prices or groceries. those are the issues on people's minds. standing by law enforcement and standing up to crime and getting past covid. it was great to see people taking their masks off yesterday as we move to the next phase here. people really want us to come together as a nation. they want us to get things done for them. domestic manufacturing, made in america. these are issues that people care about at home. it's what i hear about all the

last year, my office released a report dealing how big pharma's market consolidation creates real harms for families. too many americans can't afford lifesaving prescription drugs because big pharma buys out its competitors so that it can continue its docorporate abuse. we've also seen how big tech's market consolidation reduces consumer choice, stifles competition, and harms small businesses. competition is central to healthy capitalism. reining in corporate greed, holding big businesses accountable will strengthen our economy. congress must tackle market consolidation to create a level playing field for all businesses and to strengthen our capitalistic economy. i yield back. the speaker pro tempore: the gentlewoman yields back. the chair now recognizes the gentleman from virginia, m mr. cline, for five minutes. mr. cline: i thank the speaker. mr. speaker, last night, president biden tried to paint his administration in a positive light during the state of the union address. but the american people know better. we're facing an unprecedented number of crises, an economic crisis, a borde

curran: when you start looking at plants and naturally occurring chemicals, big pharma's always going to be thinking about what's patentable, what can be patented. in general, you can't patent nature. you can't patent a natural compound, which is why what the pharma industry often does is, they'll pursue a naturally occurring compound, but then they'll modify the structure so that it's sort of their own private modification, so to follow the scientific path, to move from a novel chemical in a plant all the way through this clinical pipeline to an approved drug, you have to think in an incredibly reductive way. you're reducing a plant to a single compound, and then you want to see how thatompound engages with your cell biology, with your physiology in theuman body. that's incredibly reductive. cordero-lamb: and we can talk about plants, but that's just a small part of this whole picture of getting outside western dichotomies, western binarys where not only are things split into two, but one half is given higher value than the other, so male over female or white over brown. we're trying

i'm on the biggest playing field there is which is television and i fought big pharma, big tech. u.s. government. i know how to win in this setting. we need to fight these culture wars. not bringing index cards into a knife fight but talking about why our values are the right ones and they need to be respected. >> conservatism works. donald trump's policies, maybe you didn't like his tweets. but his policies of peace through strength, free and fair trade deals, less bureaucracy, secure borders, energy independence. we could use a lot of that right now. dr. oz, i'm wishing you well on the senate campaign. i'm a big supporter of it. thank you for being with us. straight ahead, more bad polls for biden as the energy crisis is waiting on. we'll bring you the latest. sarah palin, she'll join us. is she making her political comeback? she's next as we continue. all of this is humanitarian aid that the fellowship is sending from israel directly into ukraine. food, medicine, warm clothing is needed now! lives abruptly changed... look at all of these people and there are hundreds and thous

and ukraine has clinical trials for most of the big companies, big pharma companies like pfizer emerg. so no see ra sure your name. but unfortunately, we didn't receive any response from them about specific actions we need to take. for example, if eastern ukraine is invited or the whole country is, it's our. so we had to come up with our own plans and having the safety of our patients and the stuff as the highest priority and for them for these companies. our message is because clinical trials is something i do on a daily basis. i run the clinical trials unit to the hospital. we want them to come back to ukraine after we win this war and come up with even larger with more trials . because ukraine has a lot of potential in this area and we hope they will continue their work and you know, bringing the work to us and innovative medications for the patients because it's all about the patients. dogs have run, infest. chuck, thank you for speaking out there. thank you. he crane's president has made an impassioned plea to american politicians to do more to protect his country against russian

big tech never does that big pharma maneuver profit pads only big oil. movement and form everywhere european parliament member. what do you think about all of this here in our neck of the woods, nigel? >> seeing the exact thing on this side of the pond. our own oil, our own gas. we don't need it. wind turbines will heat our homes in the winter and keep our cars on the road. that is delusional. that's about the politest word can i describe it we will need renewable energy. we will need oil, gas, and coal for many, many years to come. and if these idiots think that by having gas, oil and coal produced whether it's in russia or saudi arabia or somewhere else, and then shipped to your country if they think they are saving planet. they are just not doing it at home. ukraine, western world one very big lesson. it's uncertain place having your own energy independence 21st century when everything is computerized and digitized. when we need length more than we ever have in our whole human story we must all become self-sufficient in energy and the good news is tho

two, i would like to talk about how the democrats are trying to put pressure on big pharma and removing their pharmaceutical facilities out of russia and not allowing the russian people to get medications anymore. isn't that a little backwards? taking out out on people when it is the government that is doing things? host: respond if you want to, galen. guest: this is not my area of expertise. i know in the last hour you did fact checking in terms of that, research labs in ukraine. we can refer back to that fact check that you read from the washington post. ultimately i will say that in terms of sympathy for russia in this conflict, you will find very little of it. amongst the american people. as i mentioned at the beginning while there may be some division among republican leadership and republican-aligned media, republican voters by and large do not think that russia is in the right in the conflict or support or view favorably president putin, and that is a marginal view in american life today. across party lines the vast majority of americans believe that russia is the aggressor and d

in a statement, public citizen said -- "the zients-led covid response refused to challenge big pharma's monopoly control, in the u.s. and globally, over technologies that relied crucially on public support. as a result, the united states and other rich countries failed to expand vaccine supply sufficient to meet global need." in australian appeals court has overturned a historic 2021 ruling that said the government had a duty of care to protect children from the effects of the climate catastrophe. the case was brought by eight australian teenagers ia bid to prevent the expansion of a coal mine. the ung plaintiffs could still appeal the ruling. this comes as seven youth climate activists in utah launched a new suit against their state and utah officials this week. they argue fossil fuel development violates their constitutional rights and poses an existential threat to utah's children. a u.s. federal appeals court ruled the biden administration can factor in the cost of the climate crisis in policy decisions. the decision stays a ruling from a lower court which banned the administration

i think people believe m&a is still in the cards from big pharma, pfizer making comments on m&a and hopeful step the covid pipeline, people want to bet on that and people awhat's going on with the rest of the industry where are your favorite plays? >> i'd like to believe that as much as the sector sold off and the names if you look at a 12-month chart, moderna, they have huge sell-offs and we believe not a lot changes. vertex which we called out stock's up i think 16% year to date and still think that can move higher. fate which has had more on the a 50% pullback that stock can bounce back and zylab and china stocks had a huge pullback. >> anything to specifically avoid before we go >> look. i think what we are seeing is moderna still hold rated still can have a pullback and saying that it does start to get interesting at 50 billion cap. moderna will start to get interesting. stuff there. still so many people focus on covid. >> absolutely. michael, thank you so much. >> thank you. >>> speaking of bio tech, cnbc's healthy returns summit continues on wednesday there's the sharpest minds in he

unfortunately the white house has their old antiquated talking points on the old opioid crisis when the big pharmaartels were bombing the country with 100 billion opioids and eight, nine year period. no one was really talking about it back then, but now our whole population is addictive. here's the scary part, tucker. the young kids, as young as 12, 13 years old, going on social media, bind the fake bills, and the parents are finding them dead. this has never happened in the history of the country. this isn't the same old drug crisis. these are fentanyl murders. and the cartels are building up capabilities. one example, back in october, they seized a lab in mexico. the ap reported the lab was producing 70 million blue fake pills. >> tucker: without the united states, mexico has no economy, so we probably have some leverage to stop this, maybe we should. thank you. >> thank you. >> tucker: wars bring more powers, of course, that is what people are for them. the war in ukraine is being used as big tech as a way to crackdown on russian disinformation. it's anyone who holds the wrong opinion is censor

this as big pharma backs out of russia, we've got breaking headlines on that in just a second. sunny skies for airline stocks, with domestic covid-19 cases falling and travel demand up, we've got the ceo of breeze airways on the headwind every carrier is about to face as the big names cut capacity, why breeze is announcing new routes across the country could one of them be in your city? and wildly popular italian foot king scaled from new york cities culinary to your local grocery store shelves all across the nation but with the war in ukraine smashing into the world 's wheat supply the ceo of the jarred pasta parent sovos is here on the coming pasta price panic got to stay tuned for that we begin with a fox business alert take a look at abvie, novartis and merck. they just added themselves to this growing list of companies pulling out of russia. what's significant here is that these are big pharmaceutical names. the abvie suspending operations while merck and novartis will not make further investments. all three are moving higher you've got abvie up 2.5% merck and novartis up

. >> eli lilly you've got to stay with the big cap pharma >> i think xl energy is a really good sector >> southern corp., ssco, you could go freeport or southern copper, but commodities pulled back, they're not pulling back much more here inflation means re-inflation >> i think you want to be -- i should say, do you think where you should be? it's value i don't know, but i'll take two. >> you want to be in value, not high-growth here and it's a name i've been in, trinseo, tse i would be a buyer, i would be loading up here. i think value is going to be where we're going to be running to >> do i know where i would want to be? is that what you asked initially? >> i want to be right here >> i want to be a philosophyer >> do not go anywhere. "option action" is up next merip. i'm sam morrison, my brother max recommended you. so my best friend sophie says you've been a huge help. at ameriprise financial, more than 9 out of 10 of our clients are likely to recommend us. our neighbors the garcia's, love working with you. because the advice we give is personalized. hey john reese, jr. how's your

. >> big pharma has been great, 5% month to date.p 500 is overall flat. although, today digesting a move to the upside. we're right at the borderline of is it just a bounce in an ongoing downturn or maybe it's real, you know, recovery attempt. >> does three days matter in a row? does it make some difference. >> i don't know that we necessarily need the three days. any further strength is probably better than not, but no problem with giving back part of the gains as long as we don't go below yesterday's low. >> which was. >> 42.50. >> that's going to do it for us on "squawk on the street." "techcheck" starts right now >>> happy thursday welcome to "techcheck. carl's got the day off investors are fed up with poor returns. why nasdaq is not the place to be, at least not long term plus pagerduty having its best

although we've got plenty up, to your point, broadly speaking health care, i've got many of the big pharmap this morning. >> what goes up in a recession what goes up in a recession? >> j&j. >> yeah. >> wait, recession what >> david -- >> we're having a recession? >> david, there are people in the heavy recession camp, there are people in the once we finish the raise after the first raise, the market goes up camp. there are people who think that putin won't stop until a major city is leveled camp there are people who think that china is falling apart, and alone are people who think, you know what? this is the time this is the time to buy. now, when i gave you all those negatives -- >> maybe it's -- >> very counterintuitive. >> pile on all the negatives >> so you look at non-gaap, and a lot of companies are making money. when you put in the stock positions and the stocks are going down, by the way, and you're looking at gaap, and they're not making any money in times of bad, people look to gaap, in times of good, people getnon-gaap. >> yes, they do. they get carried away with that. everybody

first, you basically created a subsidy bill for big pharma, congratulations. you didn't reduce the price. what you did is created functionally $20 billion of subsidy. to buy down the price of insulin. and you bought it down with a fraud because you're doing -- we're going to pretend that the trump administration, you know, rule in regard to rebates is in effect which was never going into effect. you made magic money again. and at the same time you just took away the pressure we could have done together to actually get a real solution to the price of insulin. some of that solution could have been something as simple as the co-op that's in construction right now that's saying they're going to bring $30 a vial, $55 a box, which is five vials, of insulin to market a year. if we were doing solutions here, the democrat's bill working with republicans would have been we're going to put it at the stack for licensing and permitting. we're going to put aside some money to make sure that they get their factory up and running in virginia as soon as possible and oh, by the

numbers i totally get it but if they are able to figure out alzheimer's, it's a holy grail in big cap pharma the stock goes to $400 easily that's not hyperbole i think on monday karen had merck as her final trade, i'm with her on that we talked about bristol myers for some time, quietly made a six-year high and still upside on that one. >> i'm with him. final trade bristol myers. i'm long lilly for the reasons he said, right, it's the holy grail, also, if -- if, but it is a big if, we don't know. and then also i like pfizer and avi which we also mentioned. >> coming up, red light for auto stocks earthquake in japan deals the sector another setback, which road is heading, but first fedex shares down almost 2%. we'll break it down next when "fast money" returns (vo) right now, the big switch is happening across the country. small businesses are fed up with big bills and 5g maps that are mostly gaps— they're switching to t-mobile for business and getting more 5g bars in more places. save over $1,000 when you switch to our ultimate business plan... ...for the lowest price ever. plus, choose from

bar clays health care conference in london tomorrow i still like bristol-myers that to me in a big cap pharma>> pete, your top pick >> it would be pfizer and the reason i say that is if you're on the right side of it, great if you're on the wrong side, not so fun $500 down to $117. today it got up to $166, finished at $150 that can be fun, but only if you're on the right side of it i love the way fopfizer trades, the dividend and this is not just a play on what's been going on for the last couple of years there's plenty within the pipeline. >> we're just getting started on "fast money. >> musk in the middle. the tesla ceo publicly defending ukraine, as tensions rage on but the ev maker is still mixed up in russian medal. plus, china stocks tank. are these names in danger of getting de-listed? the traders break down the china trade next you're watching "fast money," live from the nasdaqarts mkeite in times square. we're back right after this. and some you grow to rely on. these are the bonds worth investing in. for over 50 years, pimco has reinvented fixed income to create opportunities for in

in the last month alone, we have seen big pharma increase the price of 550 9:54 drugs with an average price hike of 6.3%. pfizer has raise prices on 125 drugs more than any other company. this came after pfizer reported record profits in 2021 from the, from their taxpayer funded covid-19 vaccines and after boosting their ceo pay 17% to $21 million. johnson and johnson executives are no different. they raise prices according, a cross all consumer health products despite a 13.6% increase in revenues last year. and projected 3 to 5 billion dollars in revenue in 2022 from their covid-19 vaccine alone. instead of giving americans a break, from skyrocketing prices, companies are pocketing these extra cash. last week it was reported that united health group spend five billion dollars buying back its own stock and paying shareholders five billion dollars in dividends in 2021. this came after it reported 24 billion dollars in profits, the largest ever in its industry history. and there, these trends aren't limited to health related goods and services. snp 500 companies 2001 earnings were up ne

and animals, sir, will surely relate to just di, you know, so that's a very big issue for the lives of pharma se in those areas which are occupied for those will still, on the, in the western part and, and central part of your brain. they are busy with day and providing food for full army and but also for the teachers which are in blockade which need the food. so they give for pre some part or they stock which they have or production which day which they have. so milk for free and other stuff, you know, this one born to another boy and that they are busy was re basil machinery and military machinery as well. you probably also already seen some videos and where i bring a farmers was directors just how the military machinery to day are our houses . yeah. and there are also many of them are they to weapons in their arms and went to defend the country. so that's basically the situation, most of the farmers, they hope to steal seed that the fields and roughly we assess that at least 70 percent of the area, which usually it was seed in the spring will be seated these this year i would take yeah. wa

he is catering to big pharma, to the oil industry, why are we causing the problem with ukraine. we've got no strategic interest over there. the thing is, if russia tries to put missiles in cuba, we were talking about nuclear war. he's not politically savvy. he knows that russia is not going to stand by and let us put bases on their border with ukraine. host: we are going to talk about the fear of nuclear war coming up. we've got about 10 minutes left in this conversation about how higher gas prices are impacting you. as with everything, prices affect those with little extra to spend. it affects people with jobs who require driving. choice in seattle. how are you today? caller: i am fine. it's the first time i've ever called in. we can't always blame it on the president. this has been going on for years. like that person said, big cars take more gas. just be grateful. we don't have anybody attacking us over here. if we have to pay more for gas right now, we will go down. we've got to worry about nothing happening. be blessed that we are safe. host: what are you doing to adjust? c

he is catering to big pharma, to the oil industry, why are we causing the problem with ukraine. we've got no strategic interest over there. the thing is, if russia tries to put missiles in cuba, we were talking about nuclear war. he's not politically savvy. he knows that russia is not going to stand by and let us put bases on their border with ukraine. host: we are going to talk about the fear of nuclear war coming up. we've got about 10 minutes left in this conversation about how higher gas prices are impacting you. as with everything, prices affect those with little extra to spend. it affects people with jobs who require driving. choice in seattle. how are you today? caller: i am fine. it's the first time i've ever called in. we can't always blame it on the president. this has been going on for years. like that person said, big cars take more gas. just be grateful. we don't have anybody attacking us over here. if we have to pay more for gas right now, we will go down. we've got to worry about nothing happening. be blessed that we are safe. host: what are you doing to adjust? c

number two i would like to talk about how the democrats are trying to put pressure on big pharma andg their pharmaceutical facilities out of russia and not allowing the russian people to get medication anymore. isn't that a little backwards? taking it out on people when it is the government that is doing things? host: go ahead and respond. guest: so i should say that this is not my area of expertise. i know in the last hour you did fact checking about the research lab in ukraine and i know you can refer back that check that you read from "the washington post." ultimately i will say that in terms of sympathy for russia in this conflict, you will find very little of it among the american people. as i mentioned at the beginning, while there may be some division among republican leadership and in republican aligned media, republican voters by in large do not think that russia is in the right in this conflict, do not support your viewpoint -- viewed favorably president putin, and that is a very marginal view in american life today. across party lines the vast majority of americans believe

and you probably know in this body, there are some people that say we should just leave big pharma alone. but i know that they do wonderful work. i know they have to have their money for research. i know that they have to be able to market their products in a free-market way. but when you have these big increases in pharmaceutical price increases, maybe a couple times a year, it's time we do something about it. and besides this clawback provision, grassley-wyden caps out-of-pocket expenses, eliminates the donor -- the donut hole in dealing with these price increases every year. it caps rising prices at the inflation price index. it also brings more sunshine and accountability, particularly to the pharmacy benefit managers. nobody seems to be able to tell us anything what goes on between the health insurance companies, the pharmaceutical companies, the p.b.m.'s and the local pharmacists, and then how that affects the consumer. and we ought to know exactly where those moneys go and what those negotiations are, and grassley-wyden does something about that. so i urge my colleagues to join wy

big war. and it says on pharma has killed least 56 people and injured 200. all those in a sheer mosque in pakistan, he knows, have been held for some of those killed in the northwest and city, a shower. police say the suicide on the 1st open fire on offices before forcing his way inside and then detonated his suicide best during friday. prayers. chinese government has such a great target to 5 and hope to see the lowest in decades. the world's 2nd largest economy is grappling with k with 19 outbreaks and a property. okay, that headlines nice continues here out there, off the upfront talk to al jazeera, we do believe that the threat of an invasion of ukraine is currently the biggest threat to international peace and security. we listen, we are focusing so much on the human tearing crisis that we forget the long term development. we meet with global news makers and talk about the stories that matters on our. as russia continues its assault on ukraine, calls for action from the international community grow louder with the bait raging on everything from the effec

a deep value screen for a note today, and a lot of oil and other big enp names were on the list we like health care, in particular, pharma little bit today. we would be adding to position in defense stocks because we see a rerating of stocks as defense budgets worldwide grow over the coming years >> yeah, lockheed moving on a report of a german purchase of f-35s today. thank you for joining us with your call today. take a look at the kweb basket of chinese internet stocks falling 9%, now down about 40% this year. jpmorgan downgrading several of those names to underweight including jd.com and alibaba the analyst behind that note calling chinese internet stocks uninvestable on a 6 to 12-month basis because of china's geopolitical risk. let's bring in deirdre bosa for more on how the street is viewing those names. kind of a catch-up call, but it does highlight all of the uncertainty around these names >> it feels like a catch-up call and it feels belated, but when you take a look at where the street is on all three of these names, pinduoduo, jd.com, and alibaba, you'll see that jpmorgan is certainly on the lower side take a

and pfizer, you know, normal times they'd go okay, pipeline pharma health care, but now can everything going on with covid, that's been a bigr for the stock. why do you like pfizer here? >> and if you remember, we liked f pfizer even before covid they've shown their ability to take advantage of whatever the environment is they are -- they deliver a product or service that we all need which is health care products and they've been an amazing player this is a rich company, and by the way, it's got a tremendous dividend yield, 3% more than twice the s&p 500. >> is the dividend yield becoming a more and more important thing for you right now? >> yes as interest rates rise, then increasingly i think people holding equities are going to want to see some deals from the equities otherwise they'll have options finally. >> well-said randall, great to have you on today. it's good to see you again >> always good seeing you. >> randall eley with the edgar lomax company sn >>> the insurance companies are not all created equally. we'll look at what's driving the gains, who is on top and what could cap gains for some of them >>> the ceo of

pharma deal. stuart: that's a big deal and i see tirrray is up 11% and general cannabis corp.gnificant gains. >> significant right there. stuart: bitcoin is back i believe at a three-week high. bitcoin at 44.8 right now. >> money chasing risk assets you're getting nothing in cash so you might as well buy into something and high inflationary environments, right and the chart is saying there's been a triangle formation, so i know, you're looking at me skeptically , but you know, algorithms pick this up and so if they see any sort of hints that prices go higher, they start bidding and buying, and that's what's happening, tailwinds suggest that bitcoin gets to 45,000 and then if we cross 50 it'll get to 54. stuart: the technical analysts, all they look at is the charts and suggest where the futures go from there. >> i want to talk about bed, bath and beyond that's my favorite stock. stuart: that's ryan's thing. >> ryan cohen. oh, yes, and four-member committee selling bye bye baby. stuart: take a look at the dow winners, ibm look at that, it's at the top of the dow winners list $1

pharma and some settlement plans have tentative approval for the judge. that is scheduled for 7:00 this morning. the state of the city -- san francisco mayor london breed laying out her plans, including biglley shift -- signs that the area might not be quite the u.s. tech hub anymore. and the pizza to all pizzas? dominoes cooking up a pizza that might be the best or worst thing of all time. looking out at the big the new york stock exchange, we are starting the day the opposite way. we are down. abc 7 at 7:00 is live, our exclusive streaming show every weekday from 7:00 to 8:00 a.m. you can download it for your phone, tablet, rok apple fe tv, and android. jobina: this is a slowdown on eastbound 92 past state route 35. speeds around 11 miles per hour in the area. the bay bridge toll plaza is packed right now. we are watching a trend of the pre-pandemic time metering li ghts. the san raphael bridge is busy for people traveling to the north bay, antioch to concord, 42 minutes, and thankfully still on time here, 16 minutes. drew: we have a wind advisory in our hills, and look at the wind speeds right now, 51 at hood mountain, the east hills gusting at 32. where we find our strongest winds in

we'll look at what's next for pharma stocks as we mark two years since the start of the pandemic and we will discuss new data showing a big to its lowest level in more than a decade. but first, we have 13 minutes to go in the trading day. we're now in the "closing bell" market zone. joining us is veritas financial group founder, greg branch stocks under pressure and accelerating the losses into the close. all 11 sectors trading in the red. the dow was up more than 300 points at session highs. we have given it all up and then some, down 176 the nasdaq also getting hit pretty hard right now. it's actually the worst of all of the major averages. down almost 2% it's been a tough week if you have been a bull, greg. down almost 3% on the s&p, and you seem more damage to come what is your expectation >> i do. i have long been a bear here, even before the geopolitical circumstances set in at the end of the day, i think there's only one outcome that will be acceptable to putin. the market keeps trying to latch on to any favorable body language or words coming from himself or zelenskyy, but there's but one outcome here he's committ